Recombinant Human MIP-3 alpha (CCL20)
Catalog No : IGX-RP435
3508.60€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant Human MIP-3 alpha (CCL20) | ||
|---|---|---|---|
| Catalog No | IGX-RP435 | ||
| Supplier’s Catalog No | IGX-RP435 | ||
| Supplier | ImuGeX | ||
| Source antigen | E. coli | ||
| Reactivity | Human | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 8 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | Beta-chemokine exodus-1, CC chemokine LARC, Liver and activation-regulated chemokine, MIP-3-alpha, Small-inducible cytokine A20, SCYA20, MIP3<br/>Recombinant Human Macrophage Inflammatory Protein-3 Alpha (CCL20) | ||
| Grade | Highly Purified | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Form | Recombinant CCL20 was lyophilized from a 0.2 μm filtered 20 mM PB,100 mM NaCl solution pH 7.5. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Description | Macrophage inflammatory protein (MIP)-3/CCL20, also known as liver and activation-regulated chemokine (LARC) or Exodus, is a member of the CC chemokine subfamily initially noted to be expressed in human liver, lung, appendix, and tonsillar crypts. MIP-3 is selectively chemotactic for CD34(+) bone marrow cell-derived immature DCs and CD45RO(+) memory T cells that express the cognate receptor CCR6. MIP-3 produced at sites of inflammation may chemoattract CCR6-expressing immature DCs to the subepithelial region of mucosal surfaces._x000D_ | ||
Product Details
© 2020 Imugex All Rights Reserved